Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
13
pubmed:dateCreated
2006-6-15
pubmed:abstractText
Renewed interest in smallpox and the need for safer vaccines have highlighted our lack of understanding of the requirements for protective immunity. Since smallpox has been eradicated, surrogate animal models of closely related orthopoxviruses, such as ectromelia virus, have been used to establish critical roles for CD8 T cells in the control of primary infection. To study the requirements for protection against secondary infection, we have used a prime-challenge regime, in which avirulent ectromelia virus was used to prime mice that were then challenged with virulent ectromelia virus. In contrast to primary infection, T cells are not required for recovery from secondary infection, since gene knockout mice deficient in CD8 T-cell function and wild-type mice acutely depleted of CD4, CD8, or both subsets were fully protected. Protection correlated with effective virus control and generation of neutralizing antibody. Notably, primed mice that lacked B cells, major histocompatibility complex class II, or CD40 succumbed to secondary infection. Thus, antibody is essential, but CD4 or CD8 T cells are not required for recovery from secondary poxvirus infection.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/16775321-10037590, http://linkedlifedata.com/resource/pubmed/commentcorrection/16775321-11034370, http://linkedlifedata.com/resource/pubmed/commentcorrection/16775321-12627361, http://linkedlifedata.com/resource/pubmed/commentcorrection/16775321-12820184, http://linkedlifedata.com/resource/pubmed/commentcorrection/16775321-12869693, http://linkedlifedata.com/resource/pubmed/commentcorrection/16775321-12925846, http://linkedlifedata.com/resource/pubmed/commentcorrection/16775321-14607890, http://linkedlifedata.com/resource/pubmed/commentcorrection/16775321-15047796, http://linkedlifedata.com/resource/pubmed/commentcorrection/16775321-15070762, http://linkedlifedata.com/resource/pubmed/commentcorrection/16775321-15128815, http://linkedlifedata.com/resource/pubmed/commentcorrection/16775321-15184649, http://linkedlifedata.com/resource/pubmed/commentcorrection/16775321-15477589, http://linkedlifedata.com/resource/pubmed/commentcorrection/16775321-15951823, http://linkedlifedata.com/resource/pubmed/commentcorrection/16775321-16123129, http://linkedlifedata.com/resource/pubmed/commentcorrection/16775321-16186218, http://linkedlifedata.com/resource/pubmed/commentcorrection/16775321-16227266, http://linkedlifedata.com/resource/pubmed/commentcorrection/16775321-16272340, http://linkedlifedata.com/resource/pubmed/commentcorrection/16775321-16775322, http://linkedlifedata.com/resource/pubmed/commentcorrection/16775321-1901381, http://linkedlifedata.com/resource/pubmed/commentcorrection/16775321-2685607, http://linkedlifedata.com/resource/pubmed/commentcorrection/16775321-7534202, http://linkedlifedata.com/resource/pubmed/commentcorrection/16775321-8011279, http://linkedlifedata.com/resource/pubmed/commentcorrection/16775321-8164737, http://linkedlifedata.com/resource/pubmed/commentcorrection/16775321-8398989, http://linkedlifedata.com/resource/pubmed/commentcorrection/16775321-8456300, http://linkedlifedata.com/resource/pubmed/commentcorrection/16775321-8970949, http://linkedlifedata.com/resource/pubmed/commentcorrection/16775321-9362539, http://linkedlifedata.com/resource/pubmed/commentcorrection/16775321-9472936
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0022-538X
pubmed:author
pubmed:issnType
Print
pubmed:volume
80
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
6333-8
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:16775321-Animals, pubmed-meshheading:16775321-Antibodies, Viral, pubmed-meshheading:16775321-Antibody Formation, pubmed-meshheading:16775321-Antigens, CD40, pubmed-meshheading:16775321-B-Lymphocytes, pubmed-meshheading:16775321-CD4-Positive T-Lymphocytes, pubmed-meshheading:16775321-CD8-Positive T-Lymphocytes, pubmed-meshheading:16775321-Disease Models, Animal, pubmed-meshheading:16775321-Ectromelia, Infectious, pubmed-meshheading:16775321-Ectromelia virus, pubmed-meshheading:16775321-Female, pubmed-meshheading:16775321-Genes, MHC Class II, pubmed-meshheading:16775321-Humans, pubmed-meshheading:16775321-Lymphocyte Depletion, pubmed-meshheading:16775321-Mice, pubmed-meshheading:16775321-Mice, Inbred BALB C, pubmed-meshheading:16775321-Mice, Knockout, pubmed-meshheading:16775321-Smallpox, pubmed-meshheading:16775321-Vaccines, Attenuated
pubmed:year
2006
pubmed:articleTitle
Protective immunity against secondary poxvirus infection is dependent on antibody but not on CD4 or CD8 T-cell function.
pubmed:affiliation
Infection and Immunology Group, Division of Immunology and Genetics, The John Curtin School of Medical Research, Australian National University, Mills Road, Acton, ACT 0200, Australia.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't